AZANTA A/S: Financial statements 2013
CVR: 28108915
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
AZANTA A/S (CVR 28108915) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 1,933,000 and a net result of DKK -10,628,000. The profit margin was -549.8%. Equity in the 2013 report amounted to DKK 11,831,000. The solvency ratio was 38.2%.
- Revenue
- DKK 1,933,000
- Gross Profit
- DKK -5,345,000
- Profit/Loss
- DKK -10,628,000
- Equity
- DKK 11,831,000
- Total Assets
- DKK 30,938,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 1.9 mio. | -5.3 mio. | -10.6 mio. | 11.8 mio. | - |
| 2012 | - | - | - | 97.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
AZANTA A/S has published its annual report for 2012.
About AZANTA A/S
AZANTA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named IPC INTERNATIONAL A/S and IPC PHARMA A/S. The management consists of Erik Niklas Eriksson. The board consists of Ina Høydal Helle (chair), Erik Niklas Eriksson and Laura Elizabeth Barrell. The company is owned by Norgine B.V.. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,135,000 and a net result of DKK 40,581,000 compared with DKK 21,695,000 the year before. Equity in the 2025 report amounted to DKK 302,123,000.